hg_199227.1

Basic information about the TSS

---

TSS ID: hg_199227.1 Species: human Chr: chrX		Start: 49043256 End: 49043267 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC001532 Distance: 5 GeneID: 7030 HGNC/MGI_ID: HGNC:11752 UniProt_ID:

Gene_name: transcription factor binding to IGHM enhancer 3 Gene_symbol: TFE3 Gene_synonyms: TFEA bHLHe33 Gene_source: HGNC:11752

TATA-Box annotation

---

Distance to TSS:	95
Nearest PromoterID:	NM_006521
Entrez ID:	7030
Nearest Unigene:	Hs.730740
Nearest Refseq:	NM_006521
Nearest Ensembl:	ENSG00000068323
Gene Name:	transcription factor binding to IGHM enhancer 3
Gene Alias:	RCCP2|RCCX1|TFEA|bHLHe33
Gene Description:	transcription factor binding to IGHM enhancer 3
Gene Type:	protein-coding
CpG%:	0.11
GC%:	0.726368
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TFE3 p2@TFE3 p3@TFE3 p4@TFE3 p5@TFE3
Sample		p1@TFE3	p2@TFE3	p3@TFE3	p4@TFE3	p5@TFE3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	44.22	2.53	0.58	0.78	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	46.13	1.62	1.21	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.16	2.51	1.16	0.96	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	39.50	2.29	0.62	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	38.69	2.25	0.45	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	35.08	2.52	0.39	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	48.15	4.36	0.22	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	48.93	1.94	1.45	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	59.84	4.27	1.50	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	95.64	9.85	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	89.34	4.85	0.81	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	100.42	4.07	2.44	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.10	4.51	1.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	47.81	4.51	0.30	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.93	4.39	0.88	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	38.73	3.02	0.75	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	42.37	3.06	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	38.81	5.91	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	50.12	6.93	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	50.85	3.16	0.75	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	46.11	5.08	0.67	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	51.10	3.80	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	42.65	3.75	0.65	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.77	3.88	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	42.05	6.19	1.55	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	43.68	4.75	0.63	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	47.25	6.04	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.63	4.72	2.83	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	47.16	3.72	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	35.29	3.44	1.09	0.00	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	45.64	3.77	1.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.97	3.91	2.93	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	42.63	4.01	1.69	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.62	5.61	1.48	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	37.58	3.18	1.31	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.07	2.30	2.11	0.00	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	41.49	1.02	2.45	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	37.07	2.62	1.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	43.76	4.59	2.43	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	41.29	3.60	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	42.82	2.59	1.41	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.48	3.22	1.32	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	39.44	4.64	2.74	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	39.69	4.20	2.97	0.00	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	45.17	2.81	1.61	0.00	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	51.41	3.49	2.79	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	44.14	3.60	2.88	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.34	3.87	2.98	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.57	4.79	3.83	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	53.99	2.63	2.63	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	64.56	5.74	2.46	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	73.16	6.45	2.22	0.00	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	54.65	4.61	4.26	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	55.01	6.96	3.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	59.24	5.05	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	54.77	3.57	2.27	0.00	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	49.46	5.14	4.82	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.61	4.40	1.89	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	52.17	3.53	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	60.00	2.24	2.80	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	51.75	3.98	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	64.90	5.44	1.36	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	48.41	3.25	3.25	0.00	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	65.32	3.19	3.55	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	52.16	2.44	3.90	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	60.50	3.47	1.49	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	54.89	0.47	3.75	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	62.26	1.66	2.32	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	41.76	2.47	3.09	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	51.67	3.67	3.97	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	60.03	6.81	1.27	0.00	0.79
Adipocyte - breast, donor2	11327-117E4	50.53	4.33	1.12	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	63.36	6.36	1.53	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	55.31	6.73	2.99	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	51.24	4.69	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	52.95	1.91	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	25.29	3.30	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	35.68	0.45	0.45	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	49.35	5.39	0.70	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	62.39	5.67	0.98	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	58.94	3.60	0.77	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	57.15	5.02	0.56	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	87.58	2.35	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	76.49	7.40	0.64	0.24	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	57.45	3.55	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	59.72	1.60	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	66.77	2.78	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	71.53	3.33	0.42	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	58.52	4.52	1.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	68.07	4.91	1.31	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	49.93	5.18	0.91	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	67.40	4.64	2.65	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	64.90	3.94	5.74	0.00	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	2.40	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	47.67	2.52	1.44	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	40.16	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	40.88	3.49	1.44	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	48.75	5.03	0.80	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	47.51	3.67	0.98	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	2.25	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	43.41	3.04	2.60	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	4.28	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.27	1.79	0.60	0.00	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	3.79	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	32.34	1.32	3.30	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	40.94	5.52	0.97	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	44.66	3.40	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.82	0.59	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	37.29	1.51	2.64	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.11	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	38.87	7.52	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	47.61	4.12	1.81	0.00	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	42.82	3.17	2.41	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.83	3.21	2.68	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	34.76	1.89	1.32	0.00	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.89	2.94	1.60	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	34.50	2.49	1.33	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	38.42	3.60	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	41.51	2.57	2.40	0.17	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.58	1.94	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	41.74	2.28	1.52	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	4.85	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	36.48	4.56	2.28	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	44.04	4.06	1.50	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	2.32	2.06	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	35.19	3.28	2.35	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.20	1.93	1.61	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.96	4.28	2.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	2.34	1.75	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.63	2.11	1.20	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	27.32	5.94	2.38	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	40.18	4.07	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	33.87	1.53	2.80	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.69	2.54	1.91	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.54	3.02	1.73	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.72	2.33	1.69	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	32.48	1.74	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	37.79	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	38.65	2.20	0.68	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	46.33	6.95	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	42.02	3.22	1.50	0.00	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.10	2.41	1.80	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	35.72	2.19	2.19	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	38.16	2.76	1.61	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	10.20	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	40.17	1.27	1.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	40.05	3.30	1.65	0.00	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.44	2.14	4.59	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.50	2.87	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.24	2.88	2.66	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	1.53	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	39.88	3.32	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.31	3.97	2.65	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	41.07	3.27	2.18	0.00	1.09
Astrocyte - cerebellum, donor1	11500-119F6	64.23	9.09	0.00	0.61	0.25
Astrocyte - cerebellum, donor2	11580-120F5	62.64	6.68	1.88	0.17	0.86
Astrocyte - cerebellum, donor3	11661-122F5	38.59	6.29	0.42	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	41.48	8.71	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	35.43	4.53	0.65	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	42.51	4.03	0.89	0.60	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.68	3.10	0.23	2.29	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	11.78	2.51	0.38	2.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.58	2.96	0.46	1.71	0.11
Basophils, donor1	12241-129G9	70.61	8.11	0.26	1.05	0.26
Basophils, donor2	12242-129H1	46.54	3.61	0.00	0.72	0.00
Basophils, donor3	12243-129H2	63.80	5.14	0.59	1.32	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	50.24	2.16	1.94	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	57.61	4.57	0.46	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	32.64	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	49.49	1.87	2.29	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	54.12	4.61	3.45	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	26.27	0.90	1.26	0.18	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.11	2.37	0.52	1.44	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.58	4.66	0.23	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.95	7.99	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	55.23	4.51	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	52.15	2.60	0.19	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	51.59	2.63	0.44	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	86.89	5.66	0.57	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	71.27	3.41	0.00	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	92.05	7.56	1.31	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	144.55	7.52	2.17	0.29	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	127.03	3.62	3.02	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	154.93	4.50	0.95	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	144.80	7.70	1.34	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	138.56	3.59	3.59	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	169.34	4.46	2.23	0.25	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	117.87	3.33	1.57	0.00	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	96.50	4.81	1.96	0.18	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	131.45	5.01	1.52	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	92.48	3.98	0.94	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	125.14	3.17	2.11	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	154.20	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	137.44	6.10	1.19	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	129.11	3.79	2.79	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	141.99	3.75	1.46	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	137.96	4.12	2.29	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	128.94	4.75	2.94	0.00	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	118.72	2.18	1.31	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	117.55	7.80	0.27	0.27	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	112.70	5.58	1.05	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	159.07	3.79	1.68	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	162.95	5.88	2.39	0.00	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	165.92	3.52	2.11	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	172.42	5.26	1.32	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	112.99	7.50	1.22	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	117.82	3.72	1.12	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	154.55	4.31	1.51	0.22	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	133.90	6.14	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	150.21	4.87	1.16	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	124.12	4.41	1.39	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	50.57	3.71	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	51.74	4.85	0.23	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	42.67	2.60	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	84.87	8.25	0.00	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	78.94	5.06	0.17	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	87.63	6.47	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	49.50	3.57	0.26	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	43.03	2.85	0.00	3.51	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	49.27	5.05	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	6.10	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.78	1.36	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	11.39	3.11	0.00	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	3.20	0.00	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	6.97	4.29	0.00	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	3.51	7.72	0.00	3.51	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	3.92	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	2.64	2.64	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	27.94	5.75	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	31.92	7.98	0.00	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	27.77	13.13	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.53	2.42	0.81	4.44	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.59	1.60	1.20	5.99	0.00
CD34+ Progenitors, donor1	11545-120B6	34.14	6.02	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	57.30	8.43	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	10.90	1.50	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	10.37	2.25	0.00	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	27.85	9.64	0.00	2.14	0.00
CD4+ T Cells, donor2	11306-117C1	26.94	7.35	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	31.72	11.59	0.61	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.31	4.59	0.00	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.52	8.31	0.22	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.78	9.20	0.29	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.22	2.37	0.00	2.84	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	7.73	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.60	6.07	0.29	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.83	5.59	0.51	0.68	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.24	7.25	0.81	0.97	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.55	4.48	0.00	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.02	4.89	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.92	6.16	0.00	3.08	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	27.83	5.90	0.42	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.82	4.57	0.21	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.05	4.34	0.33	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.52	2.72	0.00	3.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8.04	4.82	0.00	3.75	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	1.79	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.91	6.30	0.56	1.67	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	23.18	3.90	0.65	0.87	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.53	2.31	0.21	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	11.12	7.58	0.51	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	11.26	5.20	0.00	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.61	4.36	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	12.37	2.47	0.00	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	3.69	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	22.71	9.14	0.00	5.54	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	17.67	5.40	0.00	6.38	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	15.04	6.45	0.36	2.86	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	2.77	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	31.10	4.58	0.33	3.60	0.00
CD8+ T Cells, donor2	11307-117C2	30.03	4.88	0.00	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	23.23	4.54	0.00	1.77	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.47	1.15	1.15	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.42	1.44	1.44	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.58	4.10	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.01	0.90	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.96	1.20	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.33	1.14	0.45	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.77	2.61	1.09	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.32	2.37	0.79	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.29	2.35	0.94	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.60	2.42	0.30	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.30	3.20	0.87	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.65	1.87	1.07	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.45	0.00	1.31	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.67	0.46	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	0.75	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.13	2.16	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.22	2.01	1.44	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.31	1.89	0.71	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.96	3.17	1.90	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.07	2.15	1.54	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.63	2.24	1.60	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.27	2.68	1.53	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	2.76	1.58	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	1.51	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	43.36	1.61	1.61	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	5.60	0.00	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	52.09	2.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	32.90	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	41.01	3.95	1.98	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	29.68	2.42	0.63	0.32	0.32
Chondrocyte - de diff, donor1	11261-116G1	47.84	3.81	1.73	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	68.23	3.55	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	43.80	2.84	1.02	0.00	0.68
Chondrocyte - re diff, donor2	11339-117F7	42.97	4.48	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	43.27	3.64	1.62	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	37.98	4.82	0.46	0.57	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	29.29	4.06	2.35	0.00	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	35.05	4.34	1.86	0.27	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.24	7.61	0.37	2.66	0.18
Corneal Epithelial Cells, donor1	11526-119I5	60.38	2.85	1.98	0.22	0.66
Corneal Epithelial Cells, donor2	11606-120I4	40.95	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.51	2.05	1.28	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.37	2.48	1.16	0.33	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	25.86	1.26	2.52	0.00	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.64	1.62	1.73	0.11	1.73
Dendritic Cells - plasmacytoid, donor1	11228-116C4	21.87	6.15	0.00	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	21.54	3.26	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	5.32	0.00	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	27.35	1.67	0.67	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	1.76	1.17	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	1.98	0.57	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	25.56	3.15	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.18	4.07	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	37.64	3.53	1.18	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	31.38	2.45	0.53	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	28.15	4.65	0.22	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.43	2.13	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	6.77	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	37.74	2.67	1.19	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	32.28	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.99	3.69	0.28	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	36.01	1.60	1.20	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	1.57	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.18	5.47	0.12	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	22.81	1.30	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.68	4.27	0.49	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	13.65	1.14	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	57.98	6.29	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.93	2.20	0.94	0.00	0.31
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	455.47	24.75	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	481.52	35.67	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	40.56	2.20	1.47	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	95.69	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	52.55	6.57	2.46	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	25.95	2.30	1.86	0.11	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	41.93	2.60	1.19	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.69	3.52	1.21	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.40	3.82	3.82	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	44.51	3.48	1.79	0.00	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.38	2.11	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.53	2.99	1.99	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	43.09	2.72	0.91	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	44.72	1.52	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	37.06	3.00	1.42	0.16	0.47
Fibroblast - Cardiac, donor4	11452-119A3	58.80	3.94	1.21	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	37.69	2.79	1.78	0.00	1.14
Fibroblast - Cardiac, donor6	11460-119B2	41.39	3.34	2.58	0.15	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	69.94	5.23	0.40	0.80	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	43.14	0.86	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	1.46	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	180.59	6.69	6.00	0.92	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	59.19	6.95	0.51	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	38.50	0.94	1.17	0.00	1.17
Fibroblast - Dermal, donor2	11346-117G5	56.60	1.89	2.36	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	34.57	1.69	2.42	0.12	1.45
Fibroblast - Dermal, donor4	11450-119A1	49.63	3.05	1.13	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	50.07	4.36	2.27	0.00	0.70
Fibroblast - Dermal, donor6	11458-119A9	50.51	3.74	2.60	0.00	0.81
Fibroblast - Gingival, donor1	11237-116D4	56.64	4.79	1.04	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	65.24	2.36	1.31	0.00	1.57
Fibroblast - Gingival, donor2	11318-117D4	46.39	3.95	1.98	0.40	0.53
Fibroblast - Gingival, donor3	11394-118C8	75.42	4.93	1.74	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	69.61	6.23	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	54.27	5.29	1.59	0.35	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	72.49	6.24	3.59	0.16	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	63.42	6.36	1.49	0.00	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	81.52	5.65	3.18	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	66.83	8.34	2.19	0.00	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	59.31	5.18	1.23	0.41	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	49.36	4.83	3.29	0.11	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.10	7.78	0.44	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	50.30	0.00	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	56.70	4.48	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	44.95	4.64	1.90	0.00	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	178.27	12.50	2.50	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	71.33	5.59	2.80	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	82.84	7.28	1.68	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	108.80	9.34	6.09	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	83.88	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	50.24	4.66	0.58	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	54.00	4.55	1.82	0.00	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	70.68	6.12	1.84	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	70.98	3.05	3.82	0.00	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	56.97	7.29	2.70	0.27	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	53.12	4.41	1.97	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.98	1.77	1.22	0.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	106.88	7.52	6.10	0.00	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	62.81	4.01	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	45.47	4.74	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	64.50	3.77	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	81.53	2.66	1.95	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	70.16	2.37	2.76	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	47.23	3.31	3.01	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	66.50	4.97	1.94	0.11	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	77.69	2.78	1.77	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	88.44	5.41	2.79	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.69	4.01	1.60	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	62.19	5.22	2.21	0.10	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	71.03	4.23	2.42	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	86.24	7.46	2.24	0.00	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	81.37	4.27	1.71	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	81.12	3.28	1.64	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	64.87	4.69	2.02	0.21	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	70.51	3.71	1.18	0.00	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.83	1.57	1.10	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	2.61	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	49.06	3.99	1.21	0.00	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	51.53	3.38	2.86	0.00	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	43.44	5.11	3.07	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	40.57	3.83	2.30	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	42.75	5.10	0.64	3.19	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.53	7.42	0.57	2.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	19.30	4.96	0.83	1.65	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.18	3.20	2.74	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	33.09	5.15	0.99	2.18	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	15.60	5.29	1.59	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	16.63	1.96	0.33	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	40.68	6.19	0.88	1.77	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	95.82	15.83	1.27	3.67	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.28	9.97	1.60	1.97	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	72.53	11.01	0.81	2.95	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	87.84	11.15	1.24	0.99	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	86.52	7.34	1.52	0.14	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	87.42	6.10	2.03	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	71.19	6.16	0.91	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	71.75	7.10	1.62	0.87	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	97.27	8.09	2.40	1.31	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	67.66	10.93	1.18	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	60.25	8.74	0.32	1.43	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	72.61	8.04	0.89	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.23	6.86	0.40	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	55.30	7.80	0.68	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	73.60	12.06	1.33	1.24	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	70.45	18.83	0.62	0.94	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	90.00	13.49	0.34	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	48.36	9.29	0.11	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.24	9.82	0.75	0.75	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	71.87	8.98	0.61	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	63.34	12.58	0.00	1.24	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	60.64	12.22	0.58	1.38	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.87	7.50	1.00	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.75	7.49	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	56.33	13.16	0.61	1.35	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.33	7.94	0.49	0.81	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	61.58	11.23	0.64	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.35	11.09	0.76	1.14	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	52.36	4.75	0.32	1.11	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.79	8.82	0.61	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.07	7.00	0.21	0.94	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	49.84	8.78	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	51.06	9.54	0.84	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.79	5.83	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	38.24	5.62	0.53	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.26	5.36	0.46	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	46.89	7.64	0.91	0.39	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.66	5.15	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	60.65	7.74	1.29	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	75.22	8.77	0.88	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	47.60	6.94	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	81.65	6.99	0.53	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	89.38	7.87	0.81	0.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	100.90	20.59	1.27	1.78	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	119.04	15.33	0.60	6.77	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	92.60	12.63	1.85	3.24	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	87.97	14.12	0.41	4.30	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.17	7.51	0.63	1.56	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	30.52	3.96	0.00	1.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	33.67	5.53	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	12.37	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.08	3.48	0.00	1.93	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	6.42	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.53	2.60	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	24.30	2.06	0.00	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.54	3.92	0.28	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	18.30	2.94	0.33	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	7.55	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.90	3.82	0.00	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.34	4.08	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	2.29	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.17	2.37	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.44	2.90	0.83	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.80	4.14	0.46	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	15.76	2.69	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.86	3.26	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.20	6.93	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	34.58	4.11	1.03	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.42	4.72	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	4.83	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.98	6.10	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	24.73	3.19	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.60	2.47	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	5.25	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.13	5.27	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.97	3.39	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.30	4.18	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.53	1.94	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	97.01	4.57	3.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	79.42	7.07	1.66	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	75.34	7.87	2.25	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	47.26	5.07	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	29.66	3.34	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.34	3.71	0.35	0.46	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.00	2.19	1.18	0.68	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.80	2.96	0.68	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.64	2.84	0.87	0.55	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.67	2.15	1.07	0.43	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.33	0.86	0.22	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.15	2.62	0.75	0.25	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.39	2.74	0.17	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.36	3.20	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	37.49	3.92	1.12	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.04	3.03	1.30	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	79.36	5.29	3.17	0.71	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	66.11	7.99	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.55	1.75	1.75	0.35	0.87
Hepatocyte, donor1	11523-119I2	14.53	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	56.02	10.77	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	37.43	3.68	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	6.53	2.61	0.00	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	23.07	2.10	0.00	1.22	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	33.75	2.47	0.69	0.00	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	13.35	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	72.58	2.50	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	60.10	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	55.59	2.65	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	28.82	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	29.60	4.41	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	34.03	1.55	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	6.46	0.65	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	51.52	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	38.30	5.70	0.00	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	43.24	5.46	1.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	37.77	3.21	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	39.70	2.77	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	29.27	2.83	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	5.44	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	4.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	47.01	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	3.83	1.28	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	47.13	6.43	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	22.22	4.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	43.90	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	34.77	4.87	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	55.33	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	12.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	50.57	7.85	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	62.99	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	72.54	10.67	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	52.65	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	51.29	2.85	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	35.90	6.44	0.92	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	66.56	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	68.73	9.52	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	49.12	4.08	2.20	0.00	0.57
Keratinocyte - epidermal, donor2	11349-117G8	69.10	3.51	2.93	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	34.17	1.61	1.70	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	46.77	3.29	2.38	0.11	0.45
Keratocytes, donor1	11527-119I6	78.05	2.75	4.47	0.34	2.06
Keratocytes, donor2	11607-120I5	53.90	5.86	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	29.84	1.78	0.79	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	0.00	0.00	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	49.62	1.08	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	38.17	3.92	0.81	0.58	0.35
Lens Epithelial Cells, donor3	11690-122I7	28.56	2.32	0.71	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	25.14	2.85	0.59	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	20.93	2.79	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.45	4.09	0.31	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	2.15	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.80	4.10	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	19.51	3.02	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.27	2.05	1.64	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	3.79	1.01	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.73	3.24	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.94	1.98	1.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	23.07	3.49	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.40	2.59	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.56	2.09	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.52	1.91	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.37	2.88	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	26.48	2.77	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.45	4.05	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.52	3.29	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	2.96	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.09	2.93	0.59	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.67	3.98	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.67	3.39	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	24.24	2.69	1.08	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.68	2.88	1.06	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	27.48	4.67	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.31	2.93	1.68	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	19.85	2.86	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	3.44	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.39	3.01	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.93	2.65	0.21	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	2.42	3.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	24.48	3.31	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.70	3.72	0.62	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.32	1.48	1.11	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.03	3.21	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.01	3.16	0.41	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.80	2.89	1.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	2.13	0.91	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.20	3.08	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	19.91	1.78	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	20.36	3.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.19	2.65	0.47	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.77	2.86	0.36	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.21	4.57	1.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	2.83	1.41	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	28.71	3.22	0.50	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.54	6.15	1.02	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.29	3.58	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	35.29	3.07	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	32.66	2.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	31.73	4.65	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	2.11	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	2.80	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.86	4.64	1.55	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.39	3.85	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.01	2.62	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.86	4.50	1.35	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	34.96	6.50	1.63	1.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	26.70	3.08	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.23	3.53	0.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.32	4.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	28.53	4.08	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.15	2.93	0.53	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	28.34	3.59	1.51	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	29.45	3.07	1.23	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	36.69	4.08	2.45	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.44	3.12	1.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.59	4.20	1.40	0.56	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	29.88	4.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.68	2.61	1.45	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.90	4.48	1.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	29.32	2.77	1.11	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	35.00	2.47	2.47	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.24	1.84	4.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	40.29	3.45	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.61	2.69	2.69	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.06	3.96	2.83	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	29.54	3.28	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.48	6.33	1.81	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	3.59	2.15	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	3.73	2.99	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	39.39	3.34	2.60	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.46	2.58	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	2.57	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	34.65	4.66	2.33	0.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.39	1.81	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.13	4.27	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.28	2.75	2.41	1.72	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	46.16	2.68	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.05	4.71	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.12	1.85	1.48	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	1.16	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	6.35	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	40.82	5.20	4.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.89	5.09	0.73	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	4.60	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.57	4.44	1.97	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	3.76	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.72	2.01	2.51	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.05	2.70	1.35	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	5.16	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.96	3.56	1.34	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.67	4.69	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	33.65	2.64	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.21	3.11	1.56	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.51	3.50	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	34.11	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.10	1.77	2.21	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	28.54	2.31	2.31	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.82	3.04	3.04	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	35.09	2.40	2.40	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.55	3.58	1.19	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	28.56	2.43	1.82	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	6.23	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.20	4.94	3.04	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	31.50	2.58	3.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.81	2.42	3.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	38.98	2.85	1.27	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	36.78	4.26	2.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.33	1.15	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	36.00	7.71	1.54	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.73	1.41	2.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	41.43	2.27	3.97	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	43.68	4.58	3.74	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	45.42	1.57	1.57	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	37.16	3.76	5.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.49	5.11	3.72	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	31.45	3.35	5.35	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	44.91	2.67	3.21	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.56	0.40	4.45	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	37.63	4.59	1.84	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	48.90	6.22	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	3.42	6.84	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.11	3.83	3.83	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	1.09	1.64	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.00	2.67	4.01	0.45	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	44.45	6.76	3.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.74	1.33	3.98	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	4.16	4.16	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	65.87	3.19	1.60	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	21.47	2.02	3.30	0.37	3.12
Macrophage - monocyte derived, donor3	11389-118C3	48.11	3.54	3.28	0.39	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	29.74	5.31	2.12	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	56.09	2.85	2.69	0.00	0.79
Mallassez-derived cells, donor3	11930-125I4	36.69	2.64	1.11	0.00	0.28
Mammary Epithelial Cell, donor1	11273-116H4	57.99	4.09	2.39	0.40	0.50
Mammary Epithelial Cell, donor2	11350-117G9	54.15	3.19	2.03	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	42.15	1.25	1.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	6.78	2.03	3.39	0.00	1.36
Mast cell, donor1	11563-120D6	27.90	4.11	0.65	0.11	0.54
Mast cell, donor2	11565-120D8	39.52	8.62	0.30	1.78	0.59
Mast cell, donor3	11566-120D9	88.25	15.76	1.13	0.90	0.00
Mast cell, donor4	11567-120E1	48.93	11.17	0.89	0.53	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	29.50	5.77	1.77	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	21.60	4.09	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	31.78	9.87	0.34	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	42.51	6.86	0.17	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	21.69	3.18	0.00	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	32.88	2.77	0.35	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	16.52	2.32	0.29	0.58	0.14
Melanocyte - light, donor1	11274-116H5	19.51	4.94	0.94	0.71	0.24
Melanocyte - light, donor2	11351-117H1	29.35	0.00	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	23.42	0.87	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	24.37	2.29	0.42	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	21.52	2.96	0.27	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	21.96	4.82	0.54	0.54	0.27
Meningeal Cells, donor1	11493-119E8	109.42	7.44	2.11	0.12	0.74
Meningeal Cells, donor2	11573-120E7	49.30	5.28	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	48.41	5.13	1.63	0.08	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	35.93	2.57	1.14	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.08	2.42	2.21	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	149.81	9.20	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	85.03	5.23	2.62	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	44.49	1.44	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	61.62	4.02	2.33	0.21	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	45.24	2.51	3.02	0.00	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	64.83	4.61	3.30	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	2.92	3.65	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	48.49	4.09	3.68	0.20	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	49.59	3.32	0.69	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	163.93	7.43	1.49	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	60.26	6.18	1.05	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	88.73	7.12	0.30	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	84.08	0.00	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	39.06	5.12	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.29	2.13	1.06	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.85	1.88	0.63	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	3.63	0.73	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	63.64	4.51	7.16	0.00	1.33
Mesothelial Cells, donor2	12156-128G5	53.55	7.01	3.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	53.26	3.61	9.18	0.14	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	43.21	5.40	1.35	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	43.84	3.45	2.46	0.49	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.92	1.47	3.24	0.00	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	39.05	2.79	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	25.93	2.49	2.90	0.41	2.90
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	52.30	4.25	3.00	0.25	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	0.93	2.79	0.47	3.26
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	49.38	1.63	2.85	0.61	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.84	4.36	4.36	0.00	2.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	37.17	2.65	2.65	0.00	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	24.70	1.52	3.42	0.00	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	1.32	2.63	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.17	3.40	1.49	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	35.77	2.68	1.79	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	37.13	2.26	1.51	0.00	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.77	2.85	3.09	0.00	3.57
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	0.00	0.55	0.55	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	39.83	0.23	1.84	0.23	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.66	4.42	1.26	0.00	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	28.94	1.83	1.43	0.20	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	37.97	1.72	1.07	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.78	0.89	3.78	0.44	2.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	27.60	1.53	1.31	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	21.80	3.04	3.55	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	1.66	0.00	0.00	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	30.17	2.17	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	1.76	3.23	0.00	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	3.27	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	1.44	1.92	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	1.60	5.20	0.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	1.37	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	24.03	0.00	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	2.04	0.00	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	29.34	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	1.10	2.21	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	1.28	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	31.49	1.74	0.74	0.00	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	0.00	1.39	0.00	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	4.42	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	53.33	1.37	2.05	0.00	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.63	0.44	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	26.63	2.49	0.36	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.84	1.68	1.12	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.02	2.49	1.25	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.23	1.17	1.17	0.00	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	45.85	1.21	1.81	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	51.76	2.92	2.50	0.42	3.76
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	45.25	1.85	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	53.50	3.41	2.28	0.00	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	37.86	4.15	1.52	0.00	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	49.24	3.63	1.81	0.00	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	62.20	3.00	2.14	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	21.60	0.64	0.64	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.57	2.14	0.80	0.27	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	88.00	6.29	5.39	0.30	3.29
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	41.39	4.66	1.27	0.00	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	55.10	3.50	0.64	0.64	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	63.46	4.42	3.32	0.00	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	36.02	1.14	0.76	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	60.23	2.84	0.85	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	75.71	4.42	2.95	0.25	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.07	1.96	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	62.33	2.65	1.18	0.00	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	95.72	4.32	4.32	0.00	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	83.25	7.42	1.65	0.00	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	81.00	3.87	2.08	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	73.93	5.59	0.33	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	1.05	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	59.70	3.36	1.38	0.20	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	0.00	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	44.69	2.25	1.50	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	38.89	4.53	1.60	0.00	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	53.38	3.96	0.45	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.10	0.74	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	62.66	3.30	1.47	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	2.67	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	50.50	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	28.25	2.53	2.95	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	66.57	2.37	3.23	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	56.44	3.66	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	3.34	3.34	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	24.21	3.34	7.10	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	39.93	3.80	1.90	0.00	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	36.70	0.00	7.98	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	0.00	1.36	0.00	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	2.09	2.09	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.19	3.02	1.16	0.00	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.16	2.16	1.35	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.00	2.52	1.05	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.31	3.97	0.99	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	30.86	3.25	0.54	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.98	4.76	2.27	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.11	2.94	1.47	0.00	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.73	3.65	1.09	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	27.05	5.83	1.59	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.21	2.40	3.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	24.94	3.61	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.65	3.58	1.95	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.92	2.29	0.35	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.10	4.22	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	39.08	3.22	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.06	3.53	2.89	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	34.49	1.72	0.69	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.19	3.12	1.78	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	32.18	4.23	1.69	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	44.38	4.27	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	1.29	2.15	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	38.99	3.00	2.33	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.35	2.25	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	3.57	1.19	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	1.86	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	38.22	1.89	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	1.63	5.54	0.00	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.45	2.61	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.21	2.26	2.71	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	5.29	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.73	2.98	3.47	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	1.91	4.59	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	55.95	6.35	0.30	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.29	1.33	1.33	0.22	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.07	1.83	2.44	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.35	2.20	2.20	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.94	3.03	2.12	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	33.23	1.58	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	2.27	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	35.03	3.35	2.36	0.00	0.50
Myoblast, donor2	11322-117D8	47.95	5.18	3.45	0.00	1.92
Myoblast, donor3	11398-118D3	38.00	3.70	3.03	0.17	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	42.76	2.48	0.88	1.75	0.29
Natural Killer Cells, donor1	11230-116C6	31.06	6.46	0.31	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	18.39	4.82	0.00	1.81	0.00
Natural Killer Cells, donor3	11387-118C1	22.82	4.60	0.55	2.76	0.00
Neural stem cells, donor1	11275-116H6	33.39	13.07	3.27	0.36	1.45
Neural stem cells, donor2	11352-117H2	40.44	7.70	0.00	1.93	0.00
Neurons, donor1	11494-119E9	27.31	2.28	1.14	3.41	0.00
Neurons, donor2	11574-120E8	12.33	2.20	0.44	1.98	0.44
Neurons, donor3	11655-122E8	22.20	6.58	2.47	0.82	0.82
Neutrophils, donor1	11233-116C9	297.89	13.92	1.86	0.93	0.93
Neutrophils, donor2	11314-117C9	185.53	20.29	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	354.90	21.38	0.61	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	58.06	7.01	0.59	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	50.47	5.86	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	40.71	2.61	2.01	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	41.85	2.89	1.93	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	48.06	5.36	3.91	0.14	0.72
Olfactory epithelial cells, donor3	11935-125I9	51.53	5.90	1.25	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	70.52	5.06	1.46	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	49.95	3.61	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	40.41	2.77	1.06	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	16.00	4.57	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.07	1.86	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	59.41	6.45	4.10	0.20	0.20
Osteoblast, donor2	11354-117H4	56.89	2.11	2.11	0.00	0.00
Osteoblast, donor3	11426-118G4	55.99	1.96	1.78	0.36	1.42
Pancreatic stromal cells, donor1	11249-116E7	54.75	4.04	1.68	0.17	0.34
Pericytes, donor1	11491-119E6	78.44	6.90	0.33	0.45	0.11
Pericytes, donor2	11571-120E5	49.12	5.43	1.36	1.36	0.45
Pericytes, donor3	11652-122E5	51.27	4.07	2.24	0.20	0.61
Perineurial Cells, donor1	11499-119F5	54.36	3.28	0.57	0.11	0.45
Perineurial Cells, donor2	11579-120F4	37.45	3.04	1.20	0.00	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.13	5.42	0.00	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	43.34	4.90	0.24	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	39.21	4.27	0.00	1.68	0.13
Placental Epithelial Cells, donor1	11278-116H9	115.04	4.07	2.63	0.72	0.48
Placental Epithelial Cells, donor2	11355-117H5	84.28	6.65	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	75.19	7.26	3.53	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	70.25	5.70	1.90	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	48.02	4.31	1.13	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.69	3.52	2.48	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	49.31	4.05	1.35	0.68	1.13
Preadipocyte - omental, donor1	11468-119C1	52.21	7.46	1.60	0.00	0.21
Preadipocyte - omental, donor2	11329-117E6	55.00	5.67	0.87	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	56.58	4.01	1.86	0.29	1.29
Preadipocyte - perirenal, donor1	11469-119C2	62.99	2.95	1.97	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	41.15	5.84	0.92	0.31	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	55.96	4.60	5.49	0.00	3.01
Preadipocyte - subcutaneous, donor3	11428-118G6	35.76	2.21	4.09	0.00	1.87
Preadipocyte - visceral, donor1	11280-116I2	57.75	6.05	1.58	0.00	1.49
Preadipocyte - visceral, donor2	11357-117H7	42.34	5.98	1.38	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	41.38	2.61	2.19	0.10	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.76	1.66	0.30	0.75	0.00
Prostate Epithelial Cells, donor2	11331-117E8	30.06	2.84	2.03	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	19.17	1.10	1.16	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	42.71	2.62	2.51	0.11	1.03
Prostate Stromal Cells, donor2	11332-117E9	52.18	3.59	2.87	0.00	0.72
Prostate Stromal Cells, donor3	11405-118E1	50.47	6.57	0.94	0.00	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	85.04	4.38	1.82	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	45.19	4.85	0.49	0.14	0.14
Renal Epithelial Cells, donor1	11517-119H5	105.50	5.58	1.01	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	65.44	1.42	2.13	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	53.46	5.72	0.74	0.00	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	39.49	2.04	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	42.86	3.37	1.62	0.00	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.75	1.78	0.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	47.91	2.00	0.67	0.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	67.35	4.40	1.76	0.66	0.66
Renal Mesangial Cells, donor2	11598-120H5	36.37	7.52	3.76	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	47.16	4.16	1.66	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	93.95	5.64	0.00	0.00	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	46.81	3.80	1.69	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	58.82	5.79	1.35	0.00	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	36.56	2.85	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.78	4.83	0.85	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	36.02	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.61	3.76	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	54.52	8.42	0.67	2.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	4.47	0.89	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.72	3.85	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	4.06	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	58.64	7.93	0.39	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	40.52	6.16	0.40	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	52.53	8.81	0.67	0.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	54.83	8.31	0.12	1.36	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	52.91	6.18	0.93	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	47.84	8.78	1.16	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	66.13	8.21	0.00	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	45.23	7.87	0.15	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.21	6.81	0.72	0.54	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.27	6.46	0.43	1.15	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.73	6.98	0.64	0.97	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.84	6.42	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	70.16	4.78	0.57	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	43.41	5.40	0.75	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	56.37	12.03	0.19	0.94	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	49.63	5.57	0.80	0.53	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	47.89	7.69	1.07	0.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	42.20	9.36	0.00	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	56.28	5.45	0.43	1.17	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	52.98	7.29	0.84	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.72	7.69	1.37	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	51.05	7.11	0.18	1.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.64	6.25	0.98	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.77	7.79	1.21	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	74.30	6.37	1.18	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	51.39	7.14	0.79	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	49.58	6.78	0.70	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	72.57	6.01	0.41	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.68	6.19	0.44	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	36.35	5.85	1.25	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	67.43	5.52	0.54	0.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	34.06	4.43	0.68	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.56	4.63	0.58	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	85.45	6.53	0.34	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	38.00	5.62	0.69	1.10	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	41.04	8.70	0.66	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	66.81	4.09	0.17	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.65	6.51	0.74	1.04	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.05	7.20	0.80	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	46.32	5.81	0.55	0.83	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	44.29	8.33	0.00	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	53.41	7.66	0.60	1.01	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	58.86	7.53	0.38	2.17	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.38	6.64	0.00	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	38.08	5.74	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	56.67	7.59	0.00	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	69.87	10.92	0.73	0.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.28	8.52	2.43	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	62.99	4.52	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.69	7.24	2.26	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	53.32	6.89	0.30	2.40	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	51.36	6.14	0.12	1.30	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	45.04	5.76	0.00	0.85	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	3.61	0.00	1.80	0.00
Schwann Cells, donor1	11498-119F4	65.26	6.39	2.26	0.38	0.38
Schwann Cells, donor2	11578-120F3	37.43	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	41.84	5.04	1.10	0.22	0.66
Sebocyte, donor1	11220-116B5	51.49	3.29	3.83	0.00	1.64
Sebocyte, donor2	11301-117B5	34.93	5.06	4.14	0.00	0.46
Sebocyte, donor3	11378-118B1	57.71	3.50	1.65	0.00	0.41
Sertoli Cells, donor1	11255-116F4	59.64	8.28	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	67.78	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	66.34	3.87	2.46	0.35	0.00
Skeletal Muscle Cells, donor2	11358-117H8	26.75	0.72	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	65.21	4.18	1.67	0.84	2.51
Skeletal Muscle Cells, donor4	11451-119A2	35.19	3.30	2.83	0.31	0.94
Skeletal Muscle Cells, donor5	11455-119A6	38.35	3.27	1.19	0.00	1.04
Skeletal Muscle Cells, donor6	11459-119B1	39.09	2.77	2.62	0.31	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.76	4.66	1.39	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.95	4.28	1.57	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.09	3.77	3.47	0.00	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	38.50	3.12	1.52	0.67	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	87.58	5.07	5.79	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	32.75	3.85	2.06	0.14	2.06
Skin - palm, donor1	10286-104F7	10.74	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.00	2.74	1.44	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	132.50	4.09	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.48	2.34	2.47	0.00	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	35.17	2.64	1.67	0.14	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	28.83	1.13	5.49	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	58.36	4.86	5.07	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	26.01	1.50	3.45	0.00	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	63.88	1.54	1.23	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	41.13	1.78	0.67	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	64.07	2.94	2.94	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	51.27	6.19	3.76	0.22	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	49.22	7.88	3.15	0.00	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	80.35	3.09	3.09	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	66.05	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.38	3.59	2.26	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	39.45	3.32	1.77	0.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.64	1.79	1.02	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	2.28	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.69	5.61	0.59	0.00	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.16	2.99	1.42	0.00	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	79.55	5.21	4.07	0.00	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	2.13	2.13	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	68.95	3.03	2.53	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	50.07	2.38	1.43	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.85	3.39	1.47	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	36.16	4.09	1.29	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.89	3.04	1.89	0.10	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	56.30	4.64	2.32	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	34.49	2.16	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	39.45	2.39	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	100.03	7.17	4.78	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	52.46	5.65	0.55	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	53.24	5.43	0.70	0.00	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	58.03	4.78	3.87	0.00	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	47.10	3.02	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.92	2.65	3.18	0.00	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	48.87	3.46	0.53	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.19	3.38	2.13	0.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.30	3.04	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.80	3.47	1.96	0.00	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	0.75	3.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	71.07	29.72	9.05	0.00	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	66.97	5.58	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	56.04	3.53	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.37	2.19	1.88	0.00	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	57.23	3.83	1.77	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.40	3.00	1.83	0.17	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	54.66	5.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	52.96	4.61	1.15	0.00	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	49.72	3.31	4.33	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	34.03	2.07	1.32	0.38	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.77	3.35	0.84	0.28	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.12	3.35	1.42	0.17	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	67.14	3.81	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	48.20	3.18	1.22	0.00	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.04	2.65	2.65	0.22	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.32	2.34	1.76	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	65.50	4.66	0.39	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.98	2.64	2.91	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	1.12	1.49	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	77.98	3.95	2.87	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	49.97	3.12	2.84	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	60.26	2.76	1.97	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	60.44	3.56	1.02	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	77.47	2.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	54.76	3.34	0.84	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	57.75	2.75	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	39.72	4.54	2.69	0.17	0.00
Synoviocyte, donor2	11368-117I9	46.10	3.02	1.68	0.00	0.50
Synoviocyte, donor3	11440-118H9	46.92	4.69	0.00	0.00	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	103.98	5.00	3.22	0.71	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	120.90	13.87	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	87.06	7.64	2.55	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	39.00	2.58	2.58	0.22	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	30.15	2.32	1.55	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	40.09	1.72	7.44	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	57.82	6.27	0.62	0.74	0.00
Urethra, donor2	10319-105A4	35.97	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	64.82	3.72	2.66	0.00	0.80
Urothelial Cells, donor2	11600-120H7	36.05	2.40	1.60	0.00	0.40
Urothelial Cells, donor3	11681-122H7	39.42	2.98	1.15	0.00	0.00
Urothelial cells, donor0	11216-116B1	51.71	2.23	1.11	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	139.70	6.23	0.00	12.46	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	161.55	12.87	0.00	10.01	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	88.99	8.21	0.00	6.16	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	66.46	6.89	0.00	2.75	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	84.25	7.55	0.58	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	184.30	7.29	0.00	7.29	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	145.93	8.26	0.00	11.01	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	86.73	9.13	0.00	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.50	2.96	1.11	1.11	0.37
Wilms' tumor cell line:HFWT	10597-108E3	18.48	2.64	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.26	4.47	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	41.33	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.45	3.06	0.25	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3.48	1.39	0.00	1.16	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	21.49	9.97	0.00	1.31	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	12.79	2.18	0.00	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.21	4.78	0.28	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	27.28	4.02	0.21	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	23.14	3.54	1.63	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.34	2.20	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.85	4.08	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	14.37	2.33	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.50	1.29	0.18	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	30.21	2.56	0.23	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.43	1.81	0.26	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.61	1.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.59	1.39	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	22.21	1.65	0.41	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.05	0.92	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	16.21	1.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.98	2.73	0.61	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	16.37	2.41	0.24	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.61	2.90	0.22	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.01	1.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	5.57	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.34	2.26	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.78	3.93	0.87	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	13.19	2.12	0.00	1.18	0.00
adipose tissue, adult, pool1	10010-101C1	81.13	9.62	0.31	0.31	0.31
adipose, donor1	10184-103D4	17.01	4.69	1.76	0.00	0.59
adipose, donor2	10185-103D5	17.44	6.89	0.00	0.00	0.00
adipose, donor3	10186-103D6	25.87	3.54	2.18	0.00	0.27
adipose, donor4	10187-103D7	26.87	6.93	7.80	4.33	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.10	2.05	0.47	4.42	0.16
adrenal gland, adult, pool1	10081-102A9	36.38	10.91	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	36.29	3.60	0.80	1.73	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.09	3.57	2.50	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	55.18	3.25	0.70	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	50.38	5.75	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	50.38	3.54	0.59	0.88	0.00
amygdala - adult, donor10196	10167-103B5	34.39	2.37	1.19	9.49	0.00
amygdala, adult, donor10252	10151-102I7	42.58	6.89	0.61	5.68	0.20
amygdala, newborn, donor10223	10360-105E9	41.64	5.16	0.97	1.94	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	98.30	5.98	1.02	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	26.03	2.43	0.66	0.66	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	8.68	4.34	0.33	0.67	0.67
aorta, adult, pool1	10052-101G7	50.41	9.02	0.98	0.78	0.20
appendix, adult	10189-103D9	24.45	5.05	0.39	2.72	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.25	3.44	0.00	1.72	0.00
artery, adult	10190-103E1	28.53	5.43	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	71.42	9.85	2.75	0.29	1.01
b cell line:RPMI1788	10427-106D4	19.63	5.80	0.45	2.08	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	62.15	1.66	1.66	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	46.34	3.37	0.69	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	20.42	0.67	2.85	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.83	1.12	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	78.00	8.58	0.54	0.00	0.11
blood, adult, pool1	10053-101G8	17.72	6.64	0.00	8.86	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	101.05	0.86	0.00	0.00	0.86
bone marrow, adult	10192-103E3	47.24	8.10	3.37	0.67	0.67
brain, adult, donor1	10084-102B3	26.65	2.05	2.05	3.08	0.00
brain, adult, pool1	10012-101C3	30.07	7.24	0.56	8.35	0.22
brain, fetal, pool1	10085-102B4	8.01	10.69	0.00	8.01	2.67
breast carcinoma cell line:MCF7	10482-107A5	29.40	3.96	0.33	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	19.60	2.37	0.37	3.37	0.00
breast, adult, donor1	10080-102A8	116.80	10.10	1.89	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.15	2.41	0.64	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.83	3.71	0.62	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.19	2.53	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.07	1.69	0.73	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	14.58	5.17	0.00	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	23.19	1.53	0.88	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	3.17	0.32	1.27	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	21.83	6.39	0.00	0.80	0.27
caudate nucleus - adult, donor10196	10177-103C6	43.75	4.61	0.00	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	42.84	5.19	1.34	9.54	0.67
caudate nucleus, adult, donor10258	10379-105H1	16.05	6.88	0.76	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	47.24	6.96	1.46	2.93	0.00
cerebellum - adult, donor10196	10173-103C2	29.13	2.91	2.91	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	25.62	3.20	0.85	11.32	0.21
cerebellum, adult, pool1	10083-102B2	13.11	3.45	0.69	4.48	0.00
cerebellum, newborn, donor10223	10357-105E6	34.87	8.30	0.83	3.32	0.83
cerebral meninges, adult	10188-103D8	21.43	5.04	0.76	4.29	0.00
cerebrospinal fluid, donor2	10294-104G6	25.58	1.46	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.48	3.45	2.44	2.01	0.00
cervical cancer cell line:ME-180	10553-107I4	56.68	3.15	0.83	1.99	0.17
cervix, adult, pool1	10013-101C4	77.80	12.28	0.10	0.84	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	93.91	7.94	2.65	0.14	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	60.09	2.61	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	11.68	2.49	0.00	1.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	56.55	5.30	1.85	0.99	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	18.97	2.37	0.00	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	43.31	3.42	2.56	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	53.00	2.78	2.49	0.20	0.60
chorionic membrane cells, donor3	12240-129G8	55.50	2.75	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.63	2.50	0.38	0.19	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.78	2.32	1.27	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	28.76	3.08	0.26	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	27.33	3.63	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.89	3.05	0.00	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	17.67	2.36	0.59	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	12.25	4.95	0.52	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.03	10.51	0.69	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	27.93	5.55	1.21	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	23.25	3.11	0.18	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	31.17	9.12	0.00	4.94	0.00
colon, adult, donor1	10082-102B1	27.37	5.95	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	48.41	6.35	0.24	1.53	0.00
colon, fetal, donor1	10070-101I7	11.12	5.56	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.90	4.25	2.12	0.42	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.58	4.38	0.60	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	12.83	4.09	0.85	0.14	0.28
corpus callosum, adult, pool1	10042-101F6	59.04	15.26	0.44	2.87	0.11
cruciate ligament, donor2	10295-104G7	50.25	2.43	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	16.85	5.62	0.00	0.00	0.00
diencephalon, adult	10193-103E4	20.16	1.92	0.24	3.84	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.35	2.53	0.23	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	80.78	11.28	1.54	4.10	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	44.77	6.74	3.13	0.96	0.72
ductus deferens, adult	10196-103E7	89.20	14.45	0.00	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	4.32	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	4.41	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	71.69	7.76	1.40	0.74	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	78.84	9.77	0.89	1.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.95	6.45	0.43	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	40.08	2.47	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	32.09	2.42	0.91	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	42.61	1.54	1.23	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	53.85	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	22.12	4.02	1.01	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	55.64	9.42	1.45	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	36.50	3.70	0.80	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	28.79	2.56	0.89	0.33	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.22	5.17	0.44	0.33	0.11
epididymis, adult	10197-103E8	66.77	6.07	1.88	1.47	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.08	4.61	3.55	0.18	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.11	4.33	7.08	0.00	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	52.81	4.98	1.05	1.18	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	53.93	4.92	1.57	1.87	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	52.32	4.82	0.78	1.46	0.67
esophagus, adult, pool1	10015-101C6	55.53	5.10	0.53	0.42	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	67.00	6.01	11.40	0.13	1.75
eye - muscle inferior rectus, donor1	10272-104E2	26.56	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	25.30	2.98	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	24.08	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	43.72	2.91	2.91	0.00	2.91
eye, fetal, donor1	10054-101G9	24.91	4.83	0.51	1.53	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	25.64	1.67	2.31	0.00	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.66	3.09	1.90	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	26.36	6.76	0.66	10.04	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	3.00	0.30	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.80	3.02	1.10	0.00	0.46
gall bladder, adult	10198-103E9	45.39	7.00	0.72	1.45	0.00
gamma delta positive T cells, donor1	11937-126A2	22.01	5.91	0.00	4.83	0.00
gamma delta positive T cells, donor2	11938-126A3	16.43	5.60	0.00	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	47.10	5.70	0.21	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.89	2.13	0.77	1.55	0.39
gastric cancer cell line:AZ521	10549-107H9	18.20	3.93	0.82	3.12	0.16
gastric cancer cell line:GSS	10560-108A2	8.24	9.15	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	19.88	2.97	0.23	1.60	0.00
giant cell carcinoma cell line:LU65	10487-107B1	9.64	1.38	0.80	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	49.13	3.50	1.68	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.18	2.99	1.00	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	72.62	7.92	0.84	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	57.86	8.01	1.26	0.14	0.28
glioblastoma cell line:T98G	10485-107A8	60.26	7.84	0.66	0.11	0.22
glioma cell line:GI-1	10413-106B8	23.72	2.93	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	37.90	1.46	0.00	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	63.46	8.54	0.24	2.93	0.49
globus pallidus, adult, donor10258	10367-105F7	27.38	2.74	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	44.77	5.33	1.07	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	14.68	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	66.88	3.52	1.28	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	125.34	18.82	1.38	2.30	0.00
hIPS +CCl2, biol_rep2	14384-156C1	140.38	11.43	0.91	3.66	0.00
hIPS +CCl2, biol_rep3	14385-156C2	173.91	10.95	1.29	2.58	0.00
hIPS, biol_rep1	14380-156B6	205.53	2.87	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	133.06	6.17	2.06	3.43	0.00
hIPS, biol_rep3	14382-156B8	71.73	4.41	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	10.63	2.87	0.00	0.57	0.00
heart - mitral valve, adult	10205-103F7	37.67	4.48	0.30	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	34.25	3.92	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	38.30	3.33	2.50	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	22.65	4.08	0.41	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	31.09	3.41	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	43.24	4.83	0.00	0.69	0.23
heart, fetal, pool1	10046-101G1	37.48	7.39	0.31	0.82	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.70	2.78	1.23	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	20.22	3.57	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.67	2.32	0.44	0.33	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.30	3.40	0.24	0.97	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	19.30	3.44	0.40	0.40	0.40
hepatoma cell line:Li-7	10484-107A7	128.34	8.34	3.78	0.78	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	11.96	2.91	0.50	1.41	0.20
hippocampus - adult, donor10196	10169-103B7	31.23	0.95	1.89	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	47.96	5.51	0.82	2.86	0.00
hippocampus, adult, donor10258	10374-105G5	34.36	3.49	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	17.62	4.23	1.76	2.11	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	30.52	6.71	0.00	3.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.22	4.71	0.00	0.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	32.24	4.82	0.25	1.78	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	5.07	0.56	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	16.01	5.68	0.26	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	13.67	4.18	0.38	1.90	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	13.43	6.71	0.88	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.49	3.88	0.65	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	18.35	4.59	0.00	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.15	1.66	0.71	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.98	4.02	0.64	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.74	4.23	0.78	1.41	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	4.91	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	31.42	6.11	1.75	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	20.43	6.11	1.53	0.76	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.11	3.05	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	28.99	5.50	1.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.94	5.27	0.00	0.75	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.38	4.55	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.07	4.39	0.94	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	15.35	4.57	0.16	0.49	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	6.10	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.82	4.78	0.90	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	39.35	6.47	0.74	1.29	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	39.08	4.56	1.14	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.53	8.98	0.41	3.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	21.48	7.39	0.00	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	20.27	2.85	0.00	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	20.58	5.14	0.91	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	25.86	3.62	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	0.66	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.34	5.90	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.03	5.88	1.28	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	15.90	2.27	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.89	4.70	1.68	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.30	7.97	0.48	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	50.81	9.36	0.00	2.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	54.63	5.37	1.46	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.09	4.89	0.31	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.85	3.97	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	2.74	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.63	3.62	0.36	1.45	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	23.49	3.20	0.71	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	9.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	29.39	5.15	0.81	0.95	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.20	4.58	1.08	0.27	0.00
immature langerhans cells, donor1	11904-125F5	48.43	5.33	0.00	1.21	0.48
immature langerhans cells, donor2	11905-125F6	50.70	4.75	3.17	0.00	0.79
insula, adult, pool1	10039-101F3	33.03	7.38	1.51	11.17	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	23.09	0.98	1.95	0.33	0.00
kidney, adult, pool1	10017-101C8	64.48	6.71	0.60	0.70	0.30
kidney, fetal, pool1	10045-101F9	55.67	10.61	0.78	1.34	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	78.54	6.53	3.41	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.68	2.49	1.94	0.00	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.20	2.57	1.47	0.18	0.18
left atrium, adult, donor1	10079-102A7	17.98	3.27	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	14.16	2.53	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	19.97	2.19	1.37	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	35.21	5.75	5.75	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	33.15	2.72	3.26	0.00	0.54
leiomyoma cell line:15425	10571-108B4	36.18	5.10	2.19	0.00	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	70.05	2.09	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	45.10	4.96	1.18	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	81.54	4.53	2.50	0.31	0.94
liposarcoma cell line:SW 872	10726-110A6	61.41	4.87	1.10	0.12	0.00
liver, adult, pool1	10018-101C9	32.25	4.05	0.00	0.32	0.00
liver, fetal, pool1	10086-102B5	22.58	1.88	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	32.37	7.58	0.58	1.75	0.00
locus coeruleus, adult, donor10252	10165-103B3	58.69	5.72	0.55	2.21	0.55
locus coeruleus, adult, donor10258	10375-105G6	36.40	7.90	0.56	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	68.14	6.31	1.68	3.36	0.00
lung adenocarcinoma cell line:A549	10499-107C4	37.64	3.46	1.25	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	30.33	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	20.43	3.56	0.66	0.00	0.13
lung, adult, pool1	10019-101D1	76.66	7.91	0.24	0.47	0.00
lung, fetal, donor1	10068-101I5	96.18	16.55	0.29	2.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	29.33	5.96	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	18.93	0.95	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	30.68	3.07	0.22	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.74	1.21	1.06	0.91	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	146.07	12.88	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	170.80	18.47	1.45	0.83	0.21
mature adipocyte, donor3	12233-129G1	162.86	13.51	0.95	0.00	0.71
mature adipocyte, donor4	12234-129G2	118.97	10.53	0.00	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.92	8.82	0.71	3.81	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	3.38	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	40.64	7.91	0.92	5.52	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	18.74	2.54	1.27	4.13	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	14.50	2.99	0.00	3.41	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	17.72	4.73	2.36	4.05	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	37.99	7.00	0.85	4.67	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	57.79	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	29.07	2.87	0.00	3.95	0.72
medulla oblongata - adult, donor10196	10174-103C3	49.97	5.19	0.65	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	53.56	7.12	0.46	2.79	0.00
medulla oblongata, adult, pool1	10038-101F2	62.61	12.65	1.14	2.69	0.08
medulla oblongata, newborn, donor10223	10361-105F1	69.09	8.68	0.69	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	16.38	5.76	0.00	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	18.59	2.45	0.86	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	17.54	3.45	0.86	0.14	0.00
melanoma cell line:G-361	10465-106H6	12.22	3.26	0.00	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	30.03	1.63	1.63	0.00	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	1.76	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.74	1.81	0.00	2.59	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.13	3.38	2.30	0.00	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.45	3.64	2.73	0.18	2.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	46.38	1.24	1.24	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.79	2.53	0.84	0.00	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.17	4.43	1.35	0.19	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	40.95	4.86	2.78	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	42.05	2.57	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	38.99	2.19	1.84	0.23	1.50
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.02	3.58	1.19	0.00	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.68	2.70	1.62	0.14	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	46.66	2.28	1.85	0.28	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.15	2.96	1.32	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.85	2.77	2.35	0.00	1.66
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.45	0.70	1.40	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.93	2.86	1.02	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.02	3.24	1.44	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.14	2.17	0.93	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	37.85	1.82	2.51	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.95	2.10	0.84	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.96	4.18	0.75	0.00	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	43.68	4.03	1.14	0.00	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	65.16	3.31	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	39.20	2.58	3.43	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	46.73	4.63	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.91	2.74	3.20	0.46	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.30	4.09	0.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.95	3.66	2.62	0.26	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	48.06	4.01	2.16	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	54.13	2.59	0.94	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	50.09	2.03	1.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	51.09	1.57	1.96	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	54.22	5.56	1.85	0.00	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	63.45	3.75	2.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.74	3.35	1.78	0.22	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	49.75	2.40	1.68	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	2.20	7.33	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	37.59	2.69	2.35	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	60.18	1.64	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	42.96	3.01	1.72	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.90	1.95	1.30	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	5.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	43.71	1.60	1.07	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	0.82	1.64	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	34.60	1.55	1.17	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.61	1.78	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	40.21	4.87	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.84	2.53	3.17	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	47.94	2.07	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	54.60	6.11	1.63	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.05	2.38	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	60.72	2.36	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	61.09	3.12	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	60.15	4.01	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	69.78	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.83	6.88	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	100.94	5.94	2.47	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	69.53	7.85	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	83.32	3.82	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	105.98	7.25	1.61	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	93.77	4.36	2.18	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	91.23	11.40	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	95.28	7.28	1.82	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	131.05	22.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	107.08	9.06	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.70	3.97	0.40	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	62.63	3.57	1.62	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	64.17	7.13	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	88.98	3.09	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	112.69	14.41	1.42	1.42	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.35	6.26	3.24	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	102.57	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	67.61	5.65	1.54	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	115.97	5.67	3.63	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	68.70	4.40	2.69	0.00	0.73
mesothelioma cell line:Mero-48a	10852-111F6	62.00	6.86	1.11	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	69.64	3.42	3.94	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	59.24	5.11	1.02	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	59.65	4.80	1.77	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	47.62	2.28	1.04	0.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	58.14	4.14	0.83	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	37.10	1.99	3.26	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	75.16	6.49	2.73	0.34	0.68
mesothelioma cell line:NCI-H28	10845-111E8	31.55	2.54	1.53	0.25	0.00
mesothelioma cell line:No36	10857-111G2	46.97	3.59	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	81.83	4.61	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	29.94	4.99	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	64.11	9.28	0.49	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	39.49	5.56	0.18	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	77.38	9.14	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.56	2.54	1.48	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	74.87	2.76	7.14	0.00	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	18.84	4.57	0.95	1.52	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	66.16	7.39	0.92	1.85	0.92
myeloma cell line:PCM6	10474-106I6	31.82	6.13	2.77	0.00	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	90.30	6.59	1.52	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	86.89	3.14	2.94	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.74	1.89	1.23	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.56	1.03	1.25	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	45.82	4.42	1.66	1.66	0.55
neuroblastoma cell line:CHP-134	10508-107D4	15.18	8.97	0.23	1.38	0.23
neuroblastoma cell line:NB-1	10539-107G8	21.14	4.30	0.37	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	18.14	4.64	0.00	2.32	0.00
neuroblastoma cell line:NH-12	10555-107I6	11.37	4.47	0.37	0.93	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.37	4.98	0.00	0.95	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.83	4.91	0.16	1.74	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	21.74	2.82	0.00	1.61	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.15	4.45	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	50.84	3.73	4.26	0.00	1.33
neutrophil PMN, donor1	12133-128D9	44.62	29.75	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.75	3.21	0.00	0.68	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	7.20	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	60.92	4.17	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	65.43	8.15	3.68	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	29.72	6.75	0.75	9.19	0.47
occipital cortex - adult, donor10196	10172-103C1	28.85	4.12	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	41.60	7.78	1.34	6.71	0.27
occipital cortex, newborn, donor10223	10355-105E4	24.38	3.64	1.82	4.73	0.00
occipital lobe, adult, donor1	10076-102A4	20.47	5.25	0.26	4.72	2.10
occipital lobe, fetal, donor1	10073-102A1	8.58	2.15	0.43	2.57	0.00
occipital pole, adult, pool1	10036-101E9	27.28	6.23	0.95	8.91	0.79
olfactory region, adult	10195-103E6	24.84	4.39	0.19	3.63	0.19
optic nerve, donor1	10277-104E7	22.01	4.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.77	2.05	0.68	1.03	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	17.86	2.20	0.96	0.55	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.13	2.71	0.68	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.29	1.16	1.16	0.12	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	53.80	3.53	2.65	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	4.67	1.87	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	36.47	5.73	0.85	0.00	0.21
ovary, adult, pool1	10020-101D2	65.16	10.22	0.70	0.70	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	80.66	4.77	3.30	0.00	0.00
pancreas, adult, donor1	10049-101G4	10.35	2.82	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	14.82	2.24	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	90.46	5.28	0.85	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.98	6.62	2.48	0.50	0.50
paracentral gyrus, adult, pool1	10035-101E8	29.65	5.49	0.73	7.14	0.55
parietal cortex, adult, donor10258	10373-105G4	24.96	4.40	0.73	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	27.27	2.82	0.00	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	37.34	5.42	0.57	8.55	0.00
parietal lobe, adult, pool1	10034-101E7	30.93	6.34	0.70	8.90	0.35
parietal lobe, fetal, donor1	10072-101I9	5.82	2.91	0.00	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	22.43	2.24	0.75	4.49	0.37
parotid gland, adult	10199-103F1	11.72	0.62	0.00	1.85	0.00
penis, adult	10200-103F2	26.86	6.98	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.67	7.07	0.19	3.16	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.54	3.50	1.31	0.29	0.29
pineal gland - adult, donor10196	10179-103C8	36.12	5.81	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	44.42	12.44	0.59	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	34.49	12.54	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	77.91	7.08	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	87.56	14.59	1.56	2.61	0.52
pituitary gland, adult, donor10258	10378-105G9	25.54	9.36	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	57.73	7.63	0.54	1.29	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	15.76	3.84	0.13	0.93	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	105.83	6.69	0.78	0.16	0.16
pons, adult, pool1	10033-101E6	33.48	8.52	0.43	3.01	0.26
postcentral gyrus, adult, pool1	10032-101E5	26.68	5.49	0.70	12.20	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.18	5.10	1.31	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	45.38	6.90	0.73	0.18	0.18
prostate, adult, pool1	10022-101D4	58.95	11.25	0.54	1.00	0.09
putamen, adult, donor10196	10176-103C5	27.38	4.25	0.47	7.08	0.47
putamen, adult, donor10252	10152-102I8	47.06	3.92	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	120.21	5.46	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	22.47	2.66	0.48	6.52	0.00
putamen, newborn, donor10223	10365-105F5	31.49	0.75	0.00	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	45.09	4.36	1.75	1.45	0.29
rectum, fetal, donor1	10067-101I4	37.56	11.13	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	61.06	7.63	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	41.42	4.56	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	51.39	10.74	1.19	3.48	0.00
retinoblastoma cell line:Y79	10475-106I7	7.27	2.60	0.52	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.75	2.95	0.49	0.86	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.52	6.47	1.12	1.41	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	83.36	4.55	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	19.26	2.43	1.46	0.16	0.16
salivary acinar cells, donor2	11772-123I8	32.91	3.03	0.83	0.00	0.41
salivary acinar cells, donor3	11773-123I9	39.06	3.31	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	26.88	2.86	0.00	6.29	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.33	6.83	1.94	0.00	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.32	5.52	2.35	0.00	0.35
seminal vesicle, adult	10201-103F3	91.00	14.28	0.53	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.31	3.40	0.49	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	50.07	5.03	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	3.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	29.42	5.10	0.54	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	30.73	3.65	0.55	1.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.19	1.94	0.65	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	4.97	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	37.78	5.16	0.48	1.08	0.00
skeletal muscle, fetal, donor1	10066-101I3	7.04	6.03	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.30	4.42	0.63	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	13.34	4.34	0.00	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	18.91	6.93	0.00	1.89	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	5.20	0.00	5.20	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	19.28	1.32	0.99	1.32	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.78	5.79	0.00	0.80	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.47	5.88	0.22	0.65	0.44
small intestine, adult, pool1	10024-101D6	34.40	5.85	0.00	1.91	0.12
small intestine, fetal, donor1	10064-101I1	17.44	3.44	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	13.85	3.08	0.51	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	49.11	8.79	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	18.23	4.29	1.61	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	35.79	8.49	0.92	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	61.90	7.49	0.00	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	50.50	5.53	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	28.66	6.10	2.44	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	81.28	8.73	0.00	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	51.08	3.14	5.08	0.30	0.60
spleen, adult, pool1	10025-101D7	48.46	6.61	0.44	0.66	0.11
spleen, fetal, pool1	10044-101F8	66.90	8.42	0.40	2.07	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.63	3.52	0.41	1.04	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.85	1.52	1.71	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.92	1.75	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	48.48	2.74	2.35	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	42.43	4.39	1.01	0.68	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.79	2.12	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	100.69	11.42	2.54	0.00	0.85
stomach, fetal, donor1	10062-101H8	26.70	5.34	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	15.38	6.84	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	44.45	8.52	0.42	2.08	0.00
substantia nigra, adult, donor10258	10371-105G2	75.00	4.14	1.03	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	60.06	9.19	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	23.61	7.80	0.23	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	30.69	7.71	1.19	10.17	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	4.27	0.00	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.94	0.88	0.00	2.20	0.00
tenocyte, donor1	11763-123H8	82.04	2.44	1.40	0.00	1.05
tenocyte, donor2	11765-123I1	83.17	5.34	1.14	0.00	0.38
tenocyte, donor3	11768-123I4	74.87	4.45	1.48	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	35.01	7.48	0.00	2.89	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	13.41	2.47	0.00	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.66	3.87	1.08	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.80	3.43	0.38	0.76	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	68.45	11.35	0.00	3.03	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	62.27	5.34	0.44	1.31	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.54	1.63	0.00	0.98	0.00
testis, adult, pool1	10026-101D8	50.14	6.12	0.54	1.07	0.21
testis, adult, pool2	10096-102C6	28.42	3.16	0.90	0.00	0.00
thalamus - adult, donor10196	10168-103B6	50.78	8.83	1.10	4.42	0.00
thalamus, adult, donor10252	10154-103A1	53.92	10.16	1.09	2.03	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	129.33	1.54	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.24	5.11	1.32	1.65	0.16
thalamus, newborn, donor10223	10366-105F6	36.82	3.45	0.58	1.15	0.00
throat, adult	10209-103G2	24.72	6.24	1.00	1.00	0.00
throat, fetal, donor1	10061-101H7	20.72	9.75	0.30	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	10.73	3.78	0.40	1.39	0.00
thymus, adult, pool1	10027-101D9	13.02	2.19	0.00	1.39	0.00
thymus, fetal, pool1	10043-101F7	28.68	5.61	0.21	2.60	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.19	1.86	0.66	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	63.56	3.91	0.70	0.28	0.28
thyroid, adult, pool1	10028-101E1	66.81	10.82	0.56	2.89	0.37
thyroid, fetal, donor1	10060-101H6	30.32	7.12	1.05	2.11	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	26.28	5.12	0.47	0.47	0.00
tongue, fetal, donor1	10059-101H5	14.19	3.15	0.00	1.18	0.00
tonsil, adult, pool1	10047-101G2	29.95	5.11	0.60	2.30	0.20
trachea, adult, pool1	10029-101E2	46.71	4.91	0.49	0.82	0.00
trachea, fetal, donor1	10058-101H4	29.62	4.23	0.38	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	48.18	2.48	4.61	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	32.12	4.46	0.71	0.00	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	45.60	5.48	1.41	0.31	0.47
tridermal teratoma cell line:HGRT	10694-109G1	49.47	1.90	0.00	0.00	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	42.49	2.03	1.27	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	20.87	8.35	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	83.78	10.58	0.68	1.37	0.00
uterus, fetal, donor1	10055-101H1	32.76	6.14	1.02	3.07	0.00
vagina, adult	10204-103F6	51.05	5.17	0.00	1.94	1.29
vein, adult	10191-103E2	32.44	5.26	0.44	1.32	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.08	3.20	0.27	0.27	0.00